Trials / Sponsors / Synthekine
Synthekine
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With S Systemic Lupus Erythematosus, Lupus Nephritis, Systemic Sclerosis | Phase 1 | 2025-04-29 |
| Active Not Recruiting | Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic CLL/SLL, NHL, Mantle Cell Lymphoma | Phase 1 | 2023-04-23 |
| Recruiting | Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers Advanced Solid Tumor, Non Small Cell Lung Cancer, Untreated Advanced NSCLC | Phase 1 / Phase 2 | 2022-01-25 |